Trial Details
COMPLETEDBasic Information
| Clinical ID | c2654 |
|---|---|
| Identifier | NCT03155945 |
| Trial Title | Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdominal Pain |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease|Abdominal Pain |
| Interventions | DRUG: Olorinab |
Participant Information
| Sponsor | Arena Pharmaceuticals |
|---|---|
| City | Brandon |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2017-07-19 |
|---|---|
| Primary Completion Date | 2018-09-10 |
| Completion Date | 2018-09-10 |